These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 2145912)

  • 1. Methylglyoxal bis-guanylhydrazone in advanced bladder cancer.
    Von Hoff DD; Blumenstein BA; Pollock TW; Crawford ED; Weick JK; Guy JT; Eisenberger M; Fletcher WS; Natale RB
    Eur J Cancer; 1990; 26(7):848-9. PubMed ID: 2145912
    [No Abstract]   [Full Text] [Related]  

  • 2. Response of nude mouse-grown human urothelial cancer to cis-diamminedichloroplatinum(II), diammine[1,1-cyclobutanedicarboxylato(2-)-O,O'-platinum], and mitoguazone dihydrochloride.
    Kyriazis AP; Yagoda A; Kyriazis AA; Fogh J
    Cancer Res; 1985 May; 45(5):2012-5. PubMed ID: 3886128
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A phase II study of mitozolomide in metastatic transitional cell carcinoma of the bladder.
    Blackledge G; Roberts JT; Kaye S; Taylor R; Williams J; de Stavola B; Uscinska B
    Eur J Cancer Clin Oncol; 1989 Feb; 25(2):391-2. PubMed ID: 2702992
    [No Abstract]   [Full Text] [Related]  

  • 4. A phase II study of carboplatin in metastatic transitional cell carcinoma of the bladder (a report of the Medical Research Council Working Party on Urological Cancer, Subgroup in Advanced Bladder Cancer).
    Eur J Cancer Clin Oncol; 1987 Apr; 23(4):375-7. PubMed ID: 3301367
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inefficacy of methylglyoxal bis(guanylhydrazone) (MGBG) in patients with recurrent head and neck squamous cell carcinoma.
    Arteaga CL; Clark GM
    Invest New Drugs; 1989 Jul; 7(2-3):281-3. PubMed ID: 2793385
    [No Abstract]   [Full Text] [Related]  

  • 6. A phase II study of mitoguazone and vinblastine in advanced transitional cell carcinoma of the urinary tract.
    Barrett JT; Orofiamma B; Khandekar JD; Carbone PP; Comis RL; Davis TE
    Cancer; 1989 Dec; 64(12):2445-7. PubMed ID: 2684384
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of advanced transitional cell carcinoma of the bladder with continuous-infusion gallium nitrate.
    Seligman PA; Crawford ED
    J Natl Cancer Inst; 1991 Nov; 83(21):1582-4. PubMed ID: 1960756
    [No Abstract]   [Full Text] [Related]  

  • 8. Chemotherapy for advanced urothelial cancer.
    Yagoda A
    Semin Urol; 1983 Feb; 1(1):60-74. PubMed ID: 6382528
    [No Abstract]   [Full Text] [Related]  

  • 9. Induction chemotherapy with cisplatin and cyclophosphamide and maintenance chemotherapy with doxorubicin and 5-FU in advanced urinary bladder tumors.
    Sulkes A; Fuks Z
    Cancer Treat Rep; 1983 Feb; 67(2):200-1. PubMed ID: 6681734
    [No Abstract]   [Full Text] [Related]  

  • 10. [Phase II study of 5'-DFUR (Furtulon) capsule for bladder cancer].
    Kubota Y; Miura T; Shuin T; Kinoshita Y; Hosaka M; Kondo I; Moriyama M; Fukushima S; Fukuoka H; Miyai K
    Gan To Kagaku Ryoho; 1991 Oct; 18(13):2301-6. PubMed ID: 1834023
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bladder cancer: management of advanced disease.
    Chong CD
    Tex Med; 1987 Feb; 83(2):51-4. PubMed ID: 3824246
    [No Abstract]   [Full Text] [Related]  

  • 12. Phase II trial of methylglyoxal-bis-guanylhydrazone (methyl-GAG) in patients with soft-tissue sarcomas.
    Sordillo PP; Magill GB; Welt S
    Am J Clin Oncol; 1985 Aug; 8(4):316-8. PubMed ID: 3909804
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trastuzumab (Herceptin) in patients with HER-2-overexpressing metastatic or locally advanced transitional cell carcinoma of the bladder: report on 7 patients.
    Salzberg M; Borner M; Bauer JA; Morant R; Rauch D; Rochlitz C
    Eur J Cancer; 2006 Oct; 42(15):2660-1. PubMed ID: 16934972
    [No Abstract]   [Full Text] [Related]  

  • 14. Chemotherapy of metastatic bladder cancer.
    Yagoda A
    Cancer; 1980 Apr; 45(7 Suppl):1879-88. PubMed ID: 7189443
    [No Abstract]   [Full Text] [Related]  

  • 15. Cytotoxicity of methylglyoxal bis(guanylhydrazone) in combination with alpha-difluoromethylornithine against HeLa cells and mouse L1210 leukemia.
    Sunkara PS; Prakash NJ; Chang CC; Sjoerdsma A
    J Natl Cancer Inst; 1983 Mar; 70(3):505-9. PubMed ID: 6403743
    [No Abstract]   [Full Text] [Related]  

  • 16. [Drug sensitivity test of cultured human bladder cancer cells].
    Sekiguchi H
    Nihon Hinyokika Gakkai Zasshi; 1983 Jan; 74(1):25-31. PubMed ID: 6865150
    [No Abstract]   [Full Text] [Related]  

  • 17. Is there a role for induction therapy for locally advanced bladder cancer?
    Soloway MS
    Urology; 1987 Jun; 29(6):577-83. PubMed ID: 3576880
    [No Abstract]   [Full Text] [Related]  

  • 18. Phase II trial of methylglyoxal-bis(guanylhydrazone) (MGBG) in patients with refractory multiple myeloma: an Eastern Cooperative Oncology Group (ECOG) study.
    Winter JN; Ritch PS; Rosen ST; Oken MM; Wolter JM; Wiernik PH; O'Connell MJ
    Cancer Invest; 1990; 8(2):143-6. PubMed ID: 2205334
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravesical chemoprophylaxis of superficial transitional cell carcinoma of the bladder. When should the drug be given?
    Bouffioux C
    Prog Clin Biol Res; 1985; 185B():47-55. PubMed ID: 4034591
    [No Abstract]   [Full Text] [Related]  

  • 20. Gallium nitrate in advanced bladder carcinoma: Southwest Oncology Group study.
    Crawford ED; Saiers JH; Baker LH; Costanzi JH; Bukowski RM
    Urology; 1991 Oct; 38(4):355-7. PubMed ID: 1755146
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.